Evidence map›Paper›PMID 38541175›Full record

ReviewMedicina (Kaunas, Lithuania)2024

Hepatic Hemangioma: Review of Imaging and Therapeutic Strategies.

Arkadiusz Kacała, Mateusz Dorochowicz, Iwona Matus, Michał Puła, Adrian Korbecki, Michał Sobański, Jagoda Jacków-Nowicka, Dariusz Patrzałek, Dariusz Janczak, Maciej Guziński

Abstract readReview
In one paragraph

Review in Medicina (Kaunas, Lithuania), 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 33 papers.

0numbers the graph read from it
0cells of the map it votes in
33citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

33 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Diagnosis and Management of Benign Liver Tumors.The Korean journal of gastroenterology = Taehan Sohwagi Hakhoe chi · 2025
    Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Arkadiusz KacałaDepartment of General, Interventional and Neuroradiology, Wroclaw Medical University, 50-367 Wrocław, Poland.ORCID 0000-0003-2392-6466
Mateusz DorochowiczFaculty of Medicine, Wroclaw Medical University, 50-367 Wrocław, Poland.ORCID 0009-0000-0730-6123
Iwona MatusFaculty of Medicine, Wroclaw Medical University, 50-367 Wrocław, Poland.ORCID 0009-0008-5052-7202
Michał PułaDepartment of General, Interventional and Neuroradiology, Wroclaw University Hospital, 50-556 Wrocław, Poland.ORCID 0000-0002-3265-7424
Adrian KorbeckiDepartment of General, Interventional and Neuroradiology, Wroclaw University Hospital, 50-556 Wrocław, Poland.ORCID 0000-0003-0047-9819
Michał SobańskiDepartment of General, Interventional and Neuroradiology, Wroclaw University Hospital, 50-556 Wrocław, Poland.
Jagoda Jacków-NowickaDepartment of General, Interventional and Neuroradiology, Wroclaw Medical University, 50-367 Wrocław, Poland.
Dariusz PatrzałekDepartment of Vascular, General and Transplantation Surgery, Wroclaw Medical University, 50-367 Wrocław, Poland.ORCID 0000-0003-0111-263X
Dariusz JanczakDepartment of Vascular, General and Transplantation Surgery, Wroclaw Medical University, 50-367 Wrocław, Poland.
Maciej GuzińskiDepartment of General, Interventional and Neuroradiology, Wroclaw Medical University, 50-367 Wrocław, Poland.ORCID 0000-0002-9781-2114

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Hepatic hemangiomas are the most common benign liver tumors. Typically, small- to medium-sized hemangiomas are asymptomatic and discovered incidentally through the widespread use of imaging techniques. Giant hemangiomas (>5 cm) have a higher risk of complications. A variety of imaging methods are used for diagnosis. Cavernous hemangioma is the most frequent type, but radiologists must be aware of other varieties. Conservative management is often adequate, but some cases necessitate targeted interventions. Although surgery was traditionally the main treatment, the evolution of minimally invasive procedures now often recommends transarterial chemoembolization as the treatment of choice.

Indexed as

Carcinoma, HepatocellularChemoembolization, TherapeuticHemangiomaHemangioma, CavernousLiver NeoplasmsHumansMagnetic Resonance Imagingatypical hepatic hemangiomacomputed tomography (CT)contrast-enhanced ultrasound (CEUS)hepatic hemangiomasmagnetic resonance (MR)transarterial chemoembolization (TACE)ultrasound (US)

Identifiers

PMID38541175
PMCPMC10972168

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.